Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study

BACKGROUND: Immunogenicity of tumor necrosis factor alpha inhibitors (TNFis) has been recognized as an important problem that may cause loss of efficacy and adverse events such as infusion reactions. TNFis are being increasingly used among patients with Behçet syndrome (BS) and scarce data exist on...

Descripción completa

Detalles Bibliográficos
Autores principales: Esatoglu, Sinem Nihal, Akkoc-Mustafayev, Fatma Nihan, Ozguler, Yesim, Ozbakır, Fatma, Nohut, Okan K., Cevirgen, Dilsen, Hamuryudan, Vedat, Hatemi, Ibrahim, Celik, Aykut Ferhat, Yazici, Hasan, Hatemi, Gulen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782473/
https://www.ncbi.nlm.nih.gov/pubmed/33414791
http://dx.doi.org/10.3389/fimmu.2020.618973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782473/
https://www.ncbi.nlm.nih.gov/pubmed/33414791
http://dx.doi.org/10.3389/fimmu.2020.618973

Ejemplares similares